Ezetimibe not tied to higher cancer risk, mortality
(HealthDay)—Treatment with the lipid-lowering therapy ezetimibe/simvastatin is not associated with an increased risk of developing cancer or an increased risk of dying from cancer, according to research published in the ...
Nov 12, 2014
0
0